3-Mar-2026
Insider Shake-Up at ANI Pharmaceuticals Sparks Investor Buzz
TipRanks (Tue, 3-Mar 9:04 PM ET)
SVP & CFO At ANI Pharmaceuticals Buys $1.72M of Stock
Benzinga (Tue, 3-Mar 10:04 AM ET)
833K Reasons To Be Bullish On ANI Pharmaceuticals Stock
Benzinga (Tue, 3-Mar 10:04 AM ET)
SVP Of ANI Pharmaceuticals Makes $1.00M Buy
Benzinga (Tue, 3-Mar 10:03 AM ET)
SVP Of ANI Pharmaceuticals Purchased $464K In Stock
Benzinga (Tue, 3-Mar 10:03 AM ET)
ANI Pharmaceuticals Highlights Updated Non-GAAP Metrics to Investors
TipRanks (Tue, 3-Mar 7:38 AM ET)
TipRanks (Mon, 2-Mar 8:10 AM ET)
Guggenheim Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)
TipRanks (Mon, 2-Mar 7:08 AM ET)
ANI Pharmaceuticals Signals Strong Growth in 2025 Call
TipRanks (Sun, 1-Mar 7:23 PM ET)
Seeking Alpha News (Fri, 27-Feb 12:58 PM ET)
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Ani Pharmaceuticals trades on the NASDAQ stock market under the symbol ANIP.
As of March 3, 2026, ANIP stock price climbed to $76.10 with 526,277 million shares trading.
ANIP has a beta of 0.34, meaning it tends to be less sensitive to market movements. ANIP has a correlation of 0.02 to the broad based SPY ETF.
ANIP has a market cap of $1.71 billion. This is considered a Small Cap stock.
Last quarter Ani Pharmaceuticals reported $247 million in Revenue and $2.33 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.50.
In the last 3 years, ANIP traded as high as $99.50 and as low as $36.54.
The top ETF exchange traded funds that ANIP belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
ANIP has outperformed the market in the last year with a return of +23.0%, while the SPY ETF gained +15.7%. However, in the most recent history, ANIP shares have underperformed the stock market with its stock returning -7.3% in the last 3 month period and -1.6% for the last 2 week period, while SPY has returned +0.1% and -0.2%, respectively.
ANIP support price is $73.50 and resistance is $76.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIP shares will trade within this expected range on the day.